A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
Pancreatic cancer has one of the highest mortality rates among cancers, and a combination of nab-paclitaxel with gemcitabine remains the cornerstone of first-line therapy. However, major advances are required to achieve improvements in patient outcomes. For this reason, several research groups have...
שמור ב:
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | , , , |
| פורמט: | Artículo |
| שפה: | en_US |
| יצא לאור: |
2022
|
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.3390/life12030327 https://www.mdpi.com/2075-1729/12/3/327/htm |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
